» Articles » PMID: 18852231

Initial and Accrued Damage As Predictors of Mortality in Brazilian Patients with Systemic Lupus Erythematosus: a Cohort Study

Overview
Journal Lupus
Publisher Sage Publications
Specialty Rheumatology
Date 2008 Oct 15
PMID 18852231
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to investigate whether initial and accrued organ damage measured by Systemic Lupus International Collaborating Clinics (SLICC) Damage Index (SDI) predicts mortality in cohort of Brazilian patients with systemic lupus erythematosus (SLE). One hundred and five outpatients with SLE were enrolled from July 2000 to March 2001; their demographics, disease manifestations, interventions and quantified disease activity (SLEDAI) were obtained. SDI was measured at baseline and at the end of follow-up. Initial and accrued SDI prognostic values for mortality were investigated by multivariate Cox survival analysis and Kaplan-Meyer survival curves. After a median follow-up of 6.3 years, 19 patients died due to disease activity, end-organ failure, cardiovascular events, cancer and infection. Deceased patients had longer disease duration and greater initial and final SDI than survivors had. After adjustment for age, sex and disease duration, both initial and final SDI >/= 3 points were independent predictors of mortality, with hazard ratios (HRs) of 3.0 (1.1-8.2) and 4.7 (1.6-14.5), respectively. Damage accrual during follow-up was the strongest predictor of death (HR: 5.1, 2.0-13.0). Renal and pulmonary damages were the main predictors of increased mortality risk. In conclusion, baseline and accrued damage increase mortality risk in Brazilian patients with SLE. Measures to prevent damage development and progression are urgent to reduce the mortality of patients with SLE.

Citing Articles

Damage in a large systemic lupus erythematosus cohort from the Spanish Society of Rheumatology Lupus Registry (RELESSER) with emphasis on the cardiovascular system: a longitudinal analysis.

Altabas-Gonzalez I, Rua-Figueroa I, Mourino C, Roberts K, Jimenez N, Martinez-Barrio J Lupus Sci Med. 2024; 11(2.

PMID: 39097409 PMC: 11331961. DOI: 10.1136/lupus-2023-001064.


Long-term Outcomes of Patients with Systemic Lupus Erythematosus: A Multicenter Cohort Study from CSTAR Registry.

Wang Z, Li M, Ye Z, Li C, Li Z, Li X Rheumatol Immunol Res. 2022; 2(3):195-202.

PMID: 36465068 PMC: 9524789. DOI: 10.2478/rir-2021-0025.


Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies.

Ugarte-Gil M, Mak A, Leong J, Dharmadhikari B, Kow N, Reategui-Sokolova C Lupus Sci Med. 2021; 8(1).

PMID: 34930819 PMC: 8689160. DOI: 10.1136/lupus-2021-000590.


Impact of systemic lupus erythematosus disease activity, hydroxychloroquine and NSAID on the risk of subsequent organ system damage and death: analysis in a single US medical centre.

Hill D, Eudy A, Egger P, Fu Q, Petri M Lupus Sci Med. 2021; 8(1).

PMID: 33832976 PMC: 8039259. DOI: 10.1136/lupus-2020-000446.


Clinical Features and Outcomes of Neuropsychiatric Systemic Lupus Erythematosus in China.

Zhang S, Li M, Zhang L, Wang Z, Wang Q, You H J Immunol Res. 2021; 2021:1349042.

PMID: 33532504 PMC: 7834780. DOI: 10.1155/2021/1349042.